Beirne Wealth Consulting Services, LLC Amgen Inc Transaction History

Beirne Wealth Consulting Services, LLC

$285 Billion
Q3 2024

A detailed history of Beirne Wealth Consulting Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Beirne Wealth Consulting Services, LLC holds 2,772 shares of AMGN stock, worth $776,354. This represents 0.31% of its overall portfolio holdings.

Number of Shares

2,772

Previous 2,772 -0.0%

Holding current value

$776,354

Previous $866 Million 3.12%

% of portfolio

0.31%

Previous 0.35%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $45,439 - $54,850	-169 Reduced 5.75%	2,772 $788 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $15,853 - $17,884	62 Added 2.15%	2,941 $847 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $13,773 - $16,787	-61 Reduced 2.07%	2,879 $696 Million
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $4,972 - $5,690	-25 Reduced 0.84%	2,940 $661,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $15,311 - $17,843	-69 Reduced 2.27%	2,965 $738,000
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $23,585 - $28,086	-109 Reduced 3.47%	3,034 $698,000
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $24,403 - $27,138	104 Added 3.42%	3,143 $799,000
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $217,195 - $266,528	-1,098 Reduced 26.54%	3,039 $717,000
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $305,434 - $405,089	-1,676 Reduced 28.83%	4,137 $839,000
Q4 2019 Jan 14, 2020	BUY	$189.21 - $243.2 $481,917 - $619,430	2,547 Added 77.99%	5,813 $1.4 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $18,503 - $21,690	-111 Reduced 3.29%	3,266 $602,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $361 - $407	2 Added 0.06%	3,377 $642,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $602,100 - $702,843	3,375 New	3,375 $657,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.

Account

Beirne Wealth Consulting Services, LLC Amgen Inc Transaction History